Disclosed are nicotinamide compounds of Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. Also disclosed are methods of using such compounds in the treatment of at least one Btk associated condition such as for example inflammatory disease and pharmaceutical compositions comprising such compounds.

暂无附图